Allan Yarahmady
Edmonton, AB T6G2E1, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Deciphering the mechanism of protein aggregation and effects of inhibitors using single-molecule mass photometry.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 22, 2026
A metabolite extracted from Escherichia coli suppresses tau aggregation.
Journal: The Biochemical journal
Published: January 28, 2026
A metabolite extracted from E. coli suppresses tau aggregation.
Journal: The Biochemical journal
Published: January 28, 2026
Alzheimer's disease-linked risk alleles elevate microglial cGAS-associated senescence and neurodegeneration in a tauopathy model.
Journal: bioRxiv : the preprint server for biology
Published: February 08, 2024
Alzheimer's disease-linked risk alleles elevate microglial cGAS-associated senescence and neurodegeneration in a tauopathy model.
Journal: Neuron
Published: January 18, 2024
Disease-Associated Mutations in Tau Encode for Changes in Aggregate Structure Conformation.
Journal: ACS chemical neuroscience
Published: December 06, 2023
Human iPSC 4R tauopathy model uncovers modifiers of tau propagation.
Journal: bioRxiv : the preprint server for biology
Published: September 25, 2023
Native PLGA nanoparticles attenuate Aβ-seed induced tau aggregation under in vitro conditions: potential implication in Alzheimer's disease pathology.
Journal: Scientific reports
Published: August 29, 2023
Human iPSC 4R tauopathy model uncovers modifiers of tau propagation.
Journal: Cell
Published: June 10, 2023
Tau activation of microglial cGAS-IFN reduces MEF2C-mediated cognitive resilience.
Journal: Nature neuroscience
Published: May 17, 2022
Showing 1-10 of 10
Last Updated: 09/26/2026